SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001213900-16-014461
Filing Date
2016-06-24
Accepted
2016-06-24 09:51:41
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G sc13g0616wonpung_relmada.htm SC 13G 44232
  Complete submission text file 0001213900-16-014461.txt   45801
Mailing Address 275 MADISON AVENUE, SUITE 702 NEW YORK NY 10016
Business Address 275 MADISON AVENUE, SUITE 702 NEW YORK NY 10016 646-677-3853
RELMADA THERAPEUTICS, INC. (Subject) CIK: 0001553643 (see all company filings)

IRS No.: 455401931 | State of Incorp.: NV | Fiscal Year End: 0630
Type: SC 13G | Act: 34 | File No.: 005-88207 | Film No.: 161730045
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5F, DONGSAN BUILDING, 67-7 YANGJAE-DONG SEOCHO-KU, SEOUL M5 137-889
Business Address 5F, DONGSAN BUILDING, 67-7 YANGJAE-DONG SEOCHO-KU, SEOUL M5 137-889 3043456555
Wonpung Mulsan Co., Ltd. (Filed by) CIK: 0001677108 (see all company filings)

IRS No.: 000000000 | State of Incorp.: FL
Type: SC 13G